Marc-Olivier Timsit
Overview
Explore the profile of Marc-Olivier Timsit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1285
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cohen C, Mhaidly R, Croizer H, Kieffer Y, Leclere R, Vincent-Salomon A, et al.
Nat Commun
. 2024 Jan;
15(1):743.
PMID: 38272907
Chronic kidney disease (CKD) is a public health problem driven by myofibroblast accumulation, leading to interstitial fibrosis. Heterogeneity is a recently recognized characteristic in kidney fibroblasts in CKD, but the...
12.
Besombes T, Suartz C, Poinard F, Plassais C, Dariane C, Hurel S, et al.
Urology
. 2023 Dec;
184:278-282.
PMID: 38056509
Objective: To evaluate whether testicular prosthesis should be fixed. Methods: Retrospective monocentric study including 169 patients who had implantation of testicular prosthesis between January 2013 and December 2022. Patients answered...
13.
Prudhomme T, Bento L, Frontczak A, Timsit M, Boissier R
Eur Urol Focus
. 2023 Nov;
10(4):551-563.
PMID: 37993345
Context: The impact of recipient obesity on kidney transplantation (KT) outcomes remains unclear. Objective: The aim of this study was to perform a systematic review and meta-analysis to appraise all...
14.
Peyrottes A, Chicaud M, Fourniol C, Doizi S, Timsit M, Mejean A, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37834918
Background: An accurate estimation of the stone burden is the key factor for predicting retrograde intra-renal surgical outcomes. Volumetric calculations better stratify stone burden than linear measurements. We developed a...
15.
Bodard S, Boudhabhay I, Dariane C, Delavaud C, Guinebert S, Guetat P, et al.
Transplantation
. 2023 Sep;
108(2):567-578.
PMID: 37726878
Background: The overall cancer risk increases in transplant patients, including in kidney allografts. This study aimed to analyze the outcome of patients with kidney allograft malignant tumors who underwent percutaneous...
16.
Grand T, Delavaud C, Dariane C, Ramtohul T, Guinebert S, Helenon O, et al.
Eur Radiol
. 2023 Jul;
33(12):8703-8714.
PMID: 37405502
Objectives: Contrast enhancement by MRI done early after cryoablation for renal malignancies may suggest residual tumor (RT). However, we have observed MRI enhancement within 48 h of cryoablation in patients...
17.
Bodard S, Dariane C, Bibault J, Boudhabhay I, Delavaud C, Timsit M, et al.
Bull Cancer
. 2023 May;
111(7-8):720-732.
PMID: 37169604
Managing a malignant renal tumor requires, first of all, a reflection on the necessity of its treatment. It must consider the renal function, altered at the time of diagnosis in...
18.
Poinard F, Bessede T, Barrou B, Drouin S, Karam G, Branchereau J, et al.
Clin Transplant
. 2023 May;
37(9):e14998.
PMID: 37138463
Systematic screening for prostate cancer is widely recommended in candidates for renal transplant at the time of listing. There are concerns that overdiagnosis of low-risk prostate cancer may result in...
19.
Thibault C, Flechon A, Albiges L, Joly C, Barthelemy P, Gross-Goupil M, et al.
Eur J Cancer
. 2023 Apr;
186:83-90.
PMID: 37054556
Background: Renal medullary carcinoma (RMC) and collecting duct carcinoma (CDC) are rare entities with a poor outcome. First-line metastatic treatment is based on gemcitabine + platinum chemotherapy (GC) regimen but...
20.
Cambou L, Millet C, Terrier N, Malvezzi P, Timsit M, Anglicheau D, et al.
Transpl Int
. 2023 Apr;
36:10556.
PMID: 37035106
Early (<14 days) renal transplant vein thrombosis posttransplant (eRVTPT) is a rare but threatening complication. We aimed to assess eRVTPT management and the rate of functional renal transplantation. Of 11,172...